• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.

作者信息

Cura F A, Kapadia S R, L'Allier P L, Schneider J P, Kreindel M S, Silver M J, Yadav J S, Simpfendorfer C C, Raymond R R, Tuzcu E M, Franco I, Whitlow P L, Topol E J, Ellis S G

机构信息

Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.

出版信息

Am J Cardiol. 2000 Oct 1;86(7):780-2, A9. doi: 10.1016/s0002-9149(00)01081-x.

DOI:10.1016/s0002-9149(00)01081-x
PMID:11018201
Abstract

We compared in-hospital femoral complications of Angio-Seal, Perclose, and manual compression in consecutive patients who underwent percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet inhibition. Femoral closure devices have a similar overall risk profile as manual compression, even in patients treated with glycoprotein IIb/IIIa platelet inhibition, although certain rare complications such as retroperitoneal hemorrhage and severe access-site infection may be more common with the use of these devices.

摘要

相似文献

1
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.
Am J Cardiol. 2000 Oct 1;86(7):780-2, A9. doi: 10.1016/s0002-9149(00)01081-x.
2
Efficacy of invasive vascular closure devices for femoral hemostasis.侵入性血管闭合装置用于股动脉止血的疗效
Am J Cardiol. 2001 Feb 15;87(4):504. doi: 10.1016/s0002-9149(00)01547-2.
3
Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.封堵装置时代接受血小板糖蛋白IIb/IIIa抑制剂治疗患者的穿刺部位结局
Catheter Cardiovasc Interv. 2003 Jan;58(1):1-5. doi: 10.1002/ccd.10384.
4
Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices.三联抗血小板治疗不会增加使用血管闭合装置时股动脉穿刺部位的出血。
Am Heart J. 2004 Jan;147(1):31-4. doi: 10.1016/j.ahj.2003.07.019.
5
Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition.在使用糖蛋白IIb/IIIa抑制剂进行经皮冠状动脉介入治疗后，使用新型股动脉闭合装置的初步经验。
Catheter Cardiovasc Interv. 2005 Oct;66(2):185-91. doi: 10.1002/ccd.20484.
6
Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization.经皮血管重建术中接受抗凝治疗及使用IIb/IIIa受体抑制剂治疗的患者的血管闭合装置
J Am Coll Cardiol. 2002 Jul 3;40(1):78-83. doi: 10.1016/s0735-1097(02)01924-1.
7
Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.经皮冠状动脉介入术后股动脉穿刺管理：手动压迫与两种不同血管闭合装置的临床结局及患者满意度比较
J Invasive Cardiol. 2001 May;13(5):354-62.
8
Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty.
Catheter Cardiovasc Interv. 2004 Nov;63(3):284-9. doi: 10.1002/ccd.20171.
9
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel.
Catheter Cardiovasc Interv. 2005 Mar;64(3):369-72. doi: 10.1002/ccd.20257.
10
Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative study.直接凝血酶抑制剂时代经皮冠状动脉介入治疗后动脉切开术闭合装置的安全性：一项比较研究。
Catheter Cardiovasc Interv. 2013 Feb;81(2):294-300. doi: 10.1002/ccd.24393. Epub 2012 Jul 23.

引用本文的文献

1
Comparison of Exo-Seal(®) and Angio-Seal (®) for arterial puncture site closure: A randomized, multicenter, single-blind trial.Exo-Seal(®)与Angio-Seal(®)用于动脉穿刺部位闭合的比较：一项随机、多中心、单盲试验。
Herz. 2015 Aug;40(5):809-16. doi: 10.1007/s00059-015-4306-3. Epub 2015 Jun 13.
2
Access and hemostasis: femoral and popliteal approaches and closure devices-why, what, when, and how?入路与止血：股动脉和腘动脉入路及闭合装置——为何、是什么、何时以及如何？
Semin Intervent Radiol. 2014 Dec;31(4):353-60. doi: 10.1055/s-0034-1393972.
3
Vascular access and closure in coronary angiography and percutaneous intervention.
冠状动脉造影和介入治疗中的血管通路和闭合。
Nat Rev Cardiol. 2013 Jan;10(1):27-40. doi: 10.1038/nrcardio.2012.160. Epub 2012 Nov 27.
4
The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization.血管闭合装置相关血管并发症的发生频率因心脏导管插入术的适应证而异。
Clin Res Cardiol. 2011 Sep;100(9):789-95. doi: 10.1007/s00392-011-0313-4. Epub 2011 Apr 11.
5
Vascular closure device failure: frequency and implications: a propensity-matched analysis.血管闭合装置失效：频率及影响因素：一项倾向评分匹配分析。
Circ Cardiovasc Interv. 2009 Dec;2(6):549-56. doi: 10.1161/CIRCINTERVENTIONS.109.877407. Epub 2009 Oct 27.
6
Rare adverse event monitoring of medical devices with the use of an automated surveillance tool.使用自动化监测工具对医疗器械进行罕见不良事件监测。
AMIA Annu Symp Proc. 2007 Oct 11;2007:518-22.
7
A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.经皮冠状动脉介入治疗后血管封堵器的成本最小化分析。
Am J Cardiol. 2007 Mar 15;99(6):766-70. doi: 10.1016/j.amjcard.2006.10.032. Epub 2007 Jan 22.
8
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.急性ST段抬高型心肌梗死再灌注的经皮冠状动脉介入治疗建议。
Heart. 2004 Jun;90(6):e37.
9
Safety and efficacy of the Perclose suture-mediated closure device following carotid artery stenting under clopidogrel platelet blockade.
Eur Radiol. 2004 Apr;14(4):719-22. doi: 10.1007/s00330-003-2143-x. Epub 2003 Nov 11.
10
Femoral hemostasis.股动脉止血。
Tex Heart Inst J. 2001;28(1):76-7.